Source: International Congress 2019 – Clinical approach to asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Wiegman (Leeuwarden, Netherlands), J. Kroes (Leeuwarden, Netherlands), A. Van Der Meer (Leeuwarden, Netherlands), R. Gijtenbeek (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands). Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma. 2715

Member's Comments

No comment yet.

Related content which might interest you: Effects of therapy for rhinosinusitis in signs and symptoms of asthma in children Source: Eur Respir J 2007; 30: Suppl. 51, 383s Year: 2007 Impact of chronic rhinosinusitis on clinical presentation in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 238s Year: 2006 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017 Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema Source: Eur Respir J 2001; 17: 596-603 Year: 2001 Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012 Treatment of bronchial asthma and wheezing disorders: chronic Source: ERS Skills Course 2016 Year: 2016 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Eosinophilic refractory inflammation in OCS-dependent severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Late-onset persistent eosinophilic severe asthma Source: International Congress 2015 – Severe asthma phenotyping Year: 2015 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Treatment of bronchial asthma and wheezing disorders: acute Source: ERS Skills Course 2016 Year: 2016 Nocturnal respiratory symptoms in patients with chronic rhinosinusitis Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea Year: 2009 Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Source: Eur Respir J 2003; 22: 8-13 Year: 2003 Pathophysiology of non-eosinophilic severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017